Nov 22nd, 2021

Watch: #AHA21 recap and look ahead

Late-breaking science, practice-changing topics, health equity, messages from leadership and new guidelines.

Screenshot 2021 11 02 130142

Antiplatelet Therapy in Patients With Coronary Artery Disease and Acute Ischemic Stroke/Transient Ischemic Attack

Getty Images 1180201381

Join the Scientific Sessions 2022 Scavenger Hunt

Live Meeting Image

Member Connect

P104 Steven Botts Image

Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells

Getty Images 1301907602

Mark your calendar for #AHA22

Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD

Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption

Lbs02 Group Blood Patel

Update on local and global hypertension science

Getty Images 1219980553 61849bc953192

Read all about #AHA21 in your daily coverage

(from left to right): Brahmajee K. Nallamothu, MD, MPH, FAHA, Rhoda Au, PhD, Seth Martin, MD, MHS, FAHA, and Andrea Beaton, MD, FAHA

QCOR at Sessions: mHealth strategies could help treat CVD around the world

(from left to right, top to bottom rows): Corey E. Ventetuolo, MD, MS, Magdi Yacoub, OM, FRS, Karen Joynt Maddox, MD, MPH, FAHA, Gregory Lewis, MD, Marco Guazzi, MD, PhD, FAHA, Ana Macumbi, MD, PhD, FESC, Mark T. Gladwin, MD, FAHA, and William Bain, MD

The shifting profile of cardiopulmonary COVID-19 survivors

(from left to right): Jonathan P. Piccini, MD, MHS, FAHA, and Steven A. Lubitz, MD, MPH, FAHA

Late-Breaking Science: New information in cardiac disease

(from left to right): Nasrien E. Ibrahim, MD, Stefan D. Anker, MD, PhD, and Clyde W. Yancy, MD, MSc, FAHA

The latest science in heart failure